Terns Pharmaceuticals
TERN
TERN
137 hedge funds and large institutions have $229M invested in Terns Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 47 increasing their positions, 39 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
137
Holders Change
-20
Holders Change %
-12.74%
% of All Funds
1.86%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
24
Increased
47
Reduced
39
Closed
43
Calls
$989K
Puts
$410K
Net Calls
+$579K
Net Calls Change
-$2.25M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$10.4M |
| 2 |
Renaissance Technologies
New York
|
+$2.24M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$1.77M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.7M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.47M |
Top Sellers
| 1 |
VA
VR Adviser
New York
|
-$5.97M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$5.88M |
| 3 |
BCM
Boxer Capital Management
San Diego,
California
|
-$4.17M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.94M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.01M |
